99% Savings - Buy Just @1 Rs X
Zilamac 125 Injection is a commercial drug that is prescribed in the form of Injection. The alternative uses of Zilamac 125 Injection have also been explained below.
The optimal dosage of Zilamac 125 Injection is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Zilamac 125 Injection side effects, there are can be others also. These have been listed below. Usually, these side effects of Zilamac 125 Injection go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Zilamac 125 Injection's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Zilamac 125 Injection related warnings talks about Zilamac 125 Injection's effects on the liver, heart and kidney.
Zilamac 125 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Zilamac 125 Injection in conditions like Kidney Disease, Kidney Disease. Some other conditions that can be affected by Zilamac 125 Injection are listed in the contraindications section below.
Drug reaction of Zilamac 125 Injection with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Zilamac 125 Injection, it is important to know that it is safe while driving, and is habit-forming.
Zilamac 125 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Zilamac 125 Injection safe for pregnant women?
Zilamac can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Zilamac right away. Take your doctor's advice before taking it again.
Is the use of Zilamac 125 Injection safe during breastfeeding?
Breastfeeding women may feel side effects of Zilamac. If you see any side effects, stop taking Zilamac immediately and talk to your doctor. Take Zilamac again, only after your doctor's advice.
What is the effect of Zilamac 125 Injection on the Kidneys?
Zilamac may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Zilamac 125 Injection on the Liver?
You may experience side effects on your liver after taking Zilamac. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Zilamac 125 Injection on the Heart?
Side effects of Zilamac rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Zilamac 125 Injection unless your doctor advises you to do so -
Is this Zilamac 125 Injection habit forming or addictive?
No, you will not get addicted to Zilamac 125 Injection.
Interaction between Food and Zilamac 125 Injection
Zilamac 125 Injection may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Zilamac 125 Injection
Consult your doctor before consuming alcohol while taking Zilamac 125 Injection as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Primaxin® (imipenem and cilastatin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 731
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 676-678